The global Fabry Disease Treatment Market reached a value of USD 2,500 million in 2022 and is anticipated to attain USD 5,429.73 million by 2032, displaying a robust compound annual growth rate (CAGR) of 9% throughout the forecast period. This remarkable growth is primarily propelled by the increasing prevalence of Fabry disease and the expanding utilization of advanced therapies. https://www.reportsanddata.com/report-detail/fabry-disease-treatment-market